Cargando…

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wei, Shuang, Zhang, Zun-yi, Fu, Sheng-ling, Xie, Jun-gang, Liu, Xian-sheng, Xu, Yong-jian, Zhao, Jian-ping, Xiong, Wei-ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520741/ https://www.ncbi.nlm.nih.gov/pubmed/28542138 http://dx.doi.org/10.1038/cddis.2017.254

Ejemplares similares

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2016)

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2018)

Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2019)

By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer
por: Zhang, Zun-yi, et al.
Publicado: (2014)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer
por: Chen, Yutong, et al.
Publicado: (2019)

Hsa-circRNA-G004213 promotes cisplatin sensitivity by regulating miR-513b-5p/PRPF39 in liver cancer
por: Qin, Ling, et al.
Publicado: (2021)

miR-23a suppresses pancreatic cancer cell progression by inhibiting PLK-1 expression
por: Chen, Bin, et al.
Publicado: (2022)

Corrigendum to “miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1”
por: Jia-yuan, Xu, et al.
Publicado: (2020)

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
por: Liu, Shaoqing, et al.
Publicado: (2022)

Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis [Corrigendum]
Publicado: (2020)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

hsa_circ_0008234 inhibits the progression of lung adenocarcinoma by sponging miR-574-5p
por: Jiang, Wei, et al.
Publicado: (2021)

miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro
por: Ye, Conglin, et al.
Publicado: (2021)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

miR-23b suppresses lung carcinoma cell proliferation through CCNG1
por: Han, Hongsheng, et al.
Publicado: (2019)

miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer
por: Li, Qing, et al.
Publicado: (2020)

miR-29a inhibits human retinoblastoma progression by targeting STAT3
por: Liu, Shu, et al.
Publicado: (2021)

Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
por: Sun, Zhiwei, et al.
Publicado: (2021)

Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a
por: Chi, Xiao-Jv, et al.
Publicado: (2021)

miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer
por: Ning, Tao, et al.
Publicado: (2022)

Repression of Smad4 by miR-205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines
por: Zeng, Yuanyuan, et al.
Publicado: (2021)

Corrigendum to “Clinical Significance of the Decreased Expression of hsa_circ_001242 in Oral Squamous Cell Carcinoma”
por: Sun, Shuai, et al.
Publicado: (2019)

Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A
por: Mi, Lili, et al.
Publicado: (2020)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Publicado: (2020)

Corrigendum to “miR-1-Mediated Induction of Cardiogenesis in Mesenchymal Stem Cells via Downregulation of Hes-1”
por: Huang, Feng, et al.
Publicado: (2016)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis [Corrigendum]
Publicado: (2021)

[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2023)

hsa_circ_0072389, hsa_circ_0072386, hsa_circ_0008621, hsa_circ_0072387, and hsa_circ_0072391 aggravate glioma via miR-338-5p/IKBIP
por: Liang, Jian, et al.
Publicado: (2021)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

miR-122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3
por: Nie, Wenyuan, et al.
Publicado: (2019)

hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling
por: Wei, Bo, et al.
Publicado: (2022)

Long Noncoding RNA LINC00460 Facilitates Colorectal Cancer Progression by Negatively Regulating miR-613 [Corrigendum]
Publicado: (2021)

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”
por: Wang, Hao, et al.
Publicado: (2021)

Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
por: Abukiwan, Alia, et al.
Publicado: (2023)

Circular RNA hsa-circ-000881 suppresses the progression of lung adenocarcinoma in vitro via a miR-665/PRICKLE2 axis
por: Huang, Chu, et al.
Publicado: (2021)

Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17
por: Ma, Jinhua, et al.
Publicado: (2021)

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
por: Feng, Linxiang, et al.
Publicado: (2023)

Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
por: Huang, Suning, et al.
Publicado: (2020)

miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum]
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jvv3s3lh2vujdc361taherg05v